Primary targets of fluoroquinolones in Streptococcus pneumoniae

H Fukuda1, K Hiramatsu

  • 1Central Research Laboratories, Kyorin Pharmaceutical Co., Ltd., Tochigi, Japan. fvbb0984@mb.infoweb.ne.jp

Insights

Mutations in Streptococcus pneumoniae parC confer resistance to certain fluoroquinolones, indicating topoisomerase IV is their primary target. Conversely, gyrA mutations suggest DNA gyrase is the main target for other fluoroquinolones.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Fluoroquinolones are broad-spectrum antibiotics crucial for treating bacterial infections.
  • Understanding the specific molecular targets of fluoroquinolones in bacteria like Streptococcus pneumoniae is essential for guiding antibiotic development and combating resistance.
  • Streptococcus pneumoniae is a significant human pathogen, and identifying its susceptibility patterns to different antibiotics is clinically relevant.

Purpose of the Study:

  • To elucidate the primary molecular targets of various fluoroquinolones in wild-type Streptococcus pneumoniae.
  • To investigate the mechanisms of fluoroquinolone resistance by analyzing mutations in key bacterial enzymes.

Main Methods:

  • Inducing and isolating fluoroquinolone-resistant mutants of Streptococcus pneumoniae IID553.
  • Utilizing specific fluoroquinolones (trovafloxacin, levofloxacin, norfloxacin, ciprofloxacin, gatifloxacin, sparfloxacin) for selection.
  • Analyzing mutations in the parC and gyrA genes, which encode subunits of topoisomerase IV and DNA gyrase, respectively.
  • Performing cross-resistance assays to determine the spectrum of resistance.

Main Results:

  • Mutants with parC mutations exhibited cross-resistance to trovafloxacin, levofloxacin, norfloxacin, and ciprofloxacin, but remained susceptible to gatifloxacin and sparfloxacin.
  • Mutants with gyrA mutations were resistant to gatifloxacin and sparfloxacin, but not to the other tested fluoroquinolones.
  • These findings differentiate the primary targets based on the observed resistance patterns.

Conclusions:

  • In Streptococcus pneumoniae, trovafloxacin, levofloxacin, norfloxacin, and ciprofloxacin primarily target topoisomerase IV.
  • Gatifloxacin and sparfloxacin primarily target DNA gyrase in Streptococcus pneumoniae.
  • This differential targeting has implications for understanding and overcoming fluoroquinolone resistance mechanisms.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...